Xenous Holdings (XITO) installs Dingwen Zhang as CEO after Chan exit
Rhea-AI Filing Summary
Xenous Holdings, Inc. reported a leadership change in which Jonathan Chan resigned as Chief Executive Officer and Director, effective May 8, 2026. The company states his resignation was not due to any disagreement over operations, policies, or practices.
On the same day, the Board appointed Dingwen Zhang as Executive Officer and Director, filling the vacancy. Zhang has founded and led several firms, including Soon Fund and Beishang Capital, and holds a Bachelor of Finance from Tsinghua University. He currently has no employment agreement or compensation arrangements with Xenous and no disclosed related-party transactions.
Positive
- None.
Negative
- None.
Insights
Xenous discloses a CEO transition with an immediate internal replacement.
The company reports that Jonathan Chan resigned as CEO and Director effective May 8, 2026, and that his departure did not stem from disagreements over operations, policies, or practices. This language aims to signal continuity rather than conflict.
The Board simultaneously appointed Dingwen Zhang as Executive Officer and Director, avoiding a leadership gap. Xenous also notes there is currently no employment agreement, compensation plan, or related-party transactions for Zhang. Future company disclosures may clarify his compensation structure and strategic priorities as CEO.
8-K Event Classification
Key Figures
Key Terms
Item 5.02 regulatory
Chief Executive Officer financial
Board of Directors financial
OTC financial
FAQ
What leadership change did Xenous Holdings (XITO) report in this 8-K?
Why did Jonathan Chan resign from Xenous Holdings (XITO)?
Who is the new CEO of Xenous Holdings (XITO) and what is his background?
Does Xenous Holdings (XITO) have an employment agreement with new CEO Dingwen Zhang?
AI-generated analysis. How Rhea-AI works. Not financial advice.